Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
Supply Chain Experts Discuss the Future of the U.S. Pharmaceutical Cold Chain
HDA hosted a LinkedIn Live event exploring the challenges, successes and future of the U.S. pharmaceutical cold chain. The event delved into key findings from the HDA Research Foundation’s report, The Future of the U.S. Pharmaceutical Cold Chain, and featured perspectives from Jeffrey Gainer, Business Process Senior Manager at McKesson, and Rena K. Goins, Executive Director of Global Trade and Distribution at Regeneron. HDA’s Perry Fri, EVP of Industry Relations and Member Services and COO of the HDA Research Foundation, moderated the discussion. Here are three takeaways from the discussion.
HDA’s Chip Davis Assesses State of the Distribution Industry at 2021 BLC Online
HDA President and CEO Chip Davis recently spoke at the 2021 BLC Online about the unique role of the healthcare distribution industry in combating COVID-19, how distributors continue to rise to its challenges and what is still needed to turn the corner on the pandemic, among other association priorities.
A Dialogue on COVID-19 Vaccines: The “Challenge of Our Time”
On January 27, HDA joined other industry experts, public health leaders and elected officials for an insightful conversation about the manufacturing, distribution and administration of COVID-19 vaccines. Speakers and panelists from across the healthcare industry shared important perspectives with Steve Clemons, Editor-in-Chief of The Hill, on what can be done to support and strengthen the largest immunization campaign in our nation’s history. Below are a few takeaways from the discussion.
HDA Chairman Kirk Kaminsky on Membership Visit to D.C. Office, Capitol Hill
After a successful first quarter, HDA welcomed its Board of Directors, members and other esteemed guests to officially open the association’s new headquarters in the nation’s capital on April 19, as well as to convene its spring governance meeting the following day. In addition to conducting the business of the HDA Board of Directors and Open House, 20 members of the Board and their executives spent time on Capitol Hill speaking with members of Congress about the value of the healthcare distribution sector.
After his first official meeting as HDA’s Chairman of the Board, Kirk Kaminsky, President, Pharmaceutical Solutions and Services for McKesson Corporation, reflected on the events and talked about his new role as HDA Chairman, HDA’s office and the importance of engagement in Washington and across the country in this Q&A blog.